Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing–remitting multiple sclerosis
Authors:
- 20 December 2014
- journal article
- Published by Wiley in European Journal of Neurology
- Vol. 22 (3) , 564-569
Abstract
Background and purpose: Vitamin D deficiency is a recognized risk factor for multiple sclerosis (MS) and is associated with increased disease activity. It has also been proposed that the lower the vitamin D levels are, the higher is the handicap.Methods: To refine the links between vitamin D insufficiency and disability in MS patients, a retrospective cohort analysis was performed including 181 patients prospectively followed without previous vitamin D supplementation, and age, gender, age at MS onset, MS type, MS activity, Expanded Disability Status Scale (EDSS) were analysed in correlation with plasma vitamin D levels.Results: Vitamin D levels were significantly higher in relapsing–remitting MS than in progressive forms of MS in multivariate analyses adjusted for age, ethnicity, gender, disease duration and season (P = 0.0487). Overall, there was a negative correlation between vitamin D level and EDSS score (P = 0.0001, r = –0.33). In relapsing–remitting MS, vitamin D levels were only correlated with disability scores for EDSS < 4 (P = 0.0012). Patients with >20 ng/ml of vitamin D were 2.78 times more likely to have an EDSS < 4 (P = 0.0011, 95% confidence interval 1.49–5.00).Conclusion: Data support previous work suggesting that vitamin D deficiency is associated with higher risk of disability in MS. Vitamin D levels also correlated with the degree of disability in fully ambulatory patients with relapsing–remitting MS. These additional results support the pertinence of randomized controlled trials analysing the interest of an early vitamin D supplementation in MS patients to influence evolution of disability.Keywords
This publication has 20 references indexed in Scilit:
- 25-Hydroxyvitamin D Levels and the Risk of StrokeStroke, 2012
- Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individualsBrain, Behavior, and Immunity, 2011
- A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolutionGenome Research, 2010
- Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosisAnnals of Neurology, 2010
- Serum Vitamin D and the Risk of Parkinson DiseaseArchives of Neurology, 2010
- Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?Brain, 2010
- Vitamin D status is associated with relapse rate in pediatric‐onset multiple sclerosisAnnals of Neurology, 2010
- 1,25‐dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte traffickingJournal of Neuroscience Research, 2007
- Natural history of multiple sclerosis: a unifying conceptBrain, 2006
- Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”Annals of Neurology, 2005